Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

BACKGROUND: Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19. METHODS:...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362594/
https://www.ncbi.nlm.nih.gov/pubmed/34351721
http://dx.doi.org/10.1056/NEJMoa2105911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362594/
https://www.ncbi.nlm.nih.gov/pubmed/34351721
http://dx.doi.org/10.1056/NEJMoa2105911

Ejemplares similares